Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

535
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
535
Relative Risk01:12

Relative Risk

2.3K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
2.3K
Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

744
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
744
Pulmonary Function Tests01:25

Pulmonary Function Tests

929
Pulmonary Function Tests (PFTs)
Pulmonary Function Tests are crucial diagnostic tools for assessing respiratory function, particularly in patients with chronic respiratory disorders. They comprehensively evaluate lung volumes, ventilatory function, breathing mechanics, diffusion, and gas exchange. These tests help diagnose pulmonary diseases and play a significant role in monitoring disease progression, evaluating disability, and assessing response to therapy.
PFTs involve using a spirometer, a...
929

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame Topic

High-sensitivity Raman spectroscopy for prostate cancer detection and tissue extraction guidance.

Biomedical optics express·2026
Same author

Dopamine-modified Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXene promotes supporting cell pluripotency and hair cell regeneration in cochlear organoid culture.

Biomaterials·2026
Same author

scVIP: personalized modeling of single-cell transcriptomes for developmental and disease phenotypes.

bioRxiv : the preprint server for biology·2026
Same author

Multi-omic profiling of human antibody-secreting cells reveals diverse subsets sustain durable humoral immunity.

bioRxiv : the preprint server for biology·2026
Same author

Comparative Effect of Non-surgical Versus Surgical Therapy for Stage III/IV Periodontitis: A Retrospective Cohort Study.

International dental journal·2026
Same author

Author Correction: Multi-omic profiling reveals age-related immune dynamics in healthy adults.

Nature·2026

Related Experiment Video

Updated: Mar 1, 2026

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.6K

An integrated risk predictor for pulmonary nodules.

Paul Kearney1, Stephen W Hunsucker1, Xiao-Jun Li1

  • 1Integrated Diagnostics, Seattle, Washington, United States of America.

Plos One
|May 26, 2017
PubMed
Summary

A new risk predictor combining clinical and molecular markers can accurately differentiate benign and malignant lung nodules. This integrated approach improves lung nodule management, reducing unnecessary invasive procedures for benign cases.

More Related Videos

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

2.2K
CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive
02:38

CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive

Published on: January 30, 2026

71

Related Experiment Videos

Last Updated: Mar 1, 2026

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules
10:26

Author Spotlight: A 3D Digital Model for the Diagnosis and Treatment of Pulmonary Nodules

Published on: May 19, 2023

2.6K
Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer
07:53

Author Spotlight: Advancing 3D Modeling for Enhanced Diagnosis and Treatment of Pulmonary Nodules in Early-Stage Lung Cancer

Published on: October 13, 2023

2.2K
CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive
02:38

CT-guided Preoperative Localization of Pulmonary Nodules Using a Glucose Test and Tissue Adhesive

Published on: January 30, 2026

71

Area of Science:

  • Pulmonology
  • Oncology
  • Biomarkers

Background:

  • Over 1.5 million lung nodules are detected annually in the US.
  • Many benign nodules undergo costly, invasive procedures to rule out malignancy.
  • ClinicalTrials.gov Identifier: NCT01752101.

Purpose of the Study:

  • To develop and assess an integrated risk predictor for lung nodules.
  • To compare the performance of clinical factors, molecular markers, and an integrated model.

Main Methods:

  • Analysis of clinical risk factors and proteomic molecular markers.
  • Development of an integrated model combining clinical and molecular data.
  • Performance assessment on a subset of 222 lung nodules (8-20mm diameter).

Main Results:

  • Proteomic molecular markers showed high predictive value for lung nodule malignancy.
  • The integrated model incorporating both clinical and molecular markers outperformed individual approaches.
  • This suggests a more efficient pathway for lung nodule management.

Conclusions:

  • An integrated risk predictor offers superior accuracy in differentiating benign from malignant lung nodules.
  • This approach can optimize patient management, guiding towards non-invasive surveillance or necessary invasive procedures.
  • Further validation of this integrated model is warranted for clinical application.